The presence of small amounts of circulating nucleic acids in plasma and serum (CNAPS) is
not a new finding. The verification that such amounts are significantly increased in cancer …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death
worldwide due to latent liver disease, late diagnosis, and nonresponse to systemic …

Lung and breast cancer are the leading causes of mortality in women worldwide. The
discovery of molecular alterations that underlie these two cancers and corresponding drugs …

Background: G-protein-coupled bile acid receptor Gpbar1 (TGR5) is a newly identified liver
tumor suppressor in carcinogenesis. This present study was therefore to determine the …

Hepatocellular carcinoma (HCC) is the sixth most common cancer and fourth leading cause
of cancer-related death worldwide. The number of HCC cases continues to rise despite …

Hepatocellular Carcinoma (HCC) is one of the most common cancers in the world and it is
often associated with poor prognosis. Liver transplantation and resection are two currently …

Background and aim Cyclins have been reported to be overexpressed with poor prognosis
in several human cancers. However, limited numbers of studies evaluated the expressions …

Revamping the current biomarker landscape of hepatocellular carcinoma (HCC) with cell-
free DNA (cfDNA) could improve overall outcomes. The use of commercially available …

Background Frequent promoter hypermethylation of the inhibitors in either Rb or p53
pathways is associated with the hepatocellular carcinoma (HCC) development. Objective To …

Although cancer-regulatory genes are dichotomized to oncogenes and tumor-suppressor
gene s, in reality they can be oncogenic in one situation but tumor-suppressive in another …